PCNA and cholangiocarcinoma: Treatment of cholangiocarcinoma CCA cells with MAG decreased malignancy and proliferation of the cells by downregulation of PCNA, Ki67, MMP-2, -7 and -9 protein expression and inhibition of the NF-κB signaling pathway [130].